These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Guidelines for the use of allergen immunotherapy. Canadian Society of Allergy and Clinical Immunology. CMAJ; 1995 May; 152(9):1413-9. PubMed ID: 7728690 [TBL] [Abstract][Full Text] [Related]
24. [New administration routes for immunotherapy]. Martorell Aragonés A Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377 [TBL] [Abstract][Full Text] [Related]
25. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes. Cox L; Esch RE; Corbett M; Hankin C; Nelson M; Plunkett G Ann Allergy Asthma Immunol; 2011 Oct; 107(4):289-99; quiz 300. PubMed ID: 21962088 [TBL] [Abstract][Full Text] [Related]
26. Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety. Caminati M; Dama AR; Djuric I; Montagni M; Schiappoli M; Ridolo E; Senna G; Canonica GW Expert Rev Clin Immunol; 2015 Feb; 11(2):233-45. PubMed ID: 25484197 [TBL] [Abstract][Full Text] [Related]
28. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. Burks AW; Calderon MA; Casale T; Cox L; Demoly P; Jutel M; Nelson H; Akdis CA J Allergy Clin Immunol; 2013 May; 131(5):1288-96.e3. PubMed ID: 23498595 [TBL] [Abstract][Full Text] [Related]
29. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. Cox L; Larenas-Linnemann D; Lockey RF; Passalacqua G J Allergy Clin Immunol; 2010 Mar; 125(3):569-74, 574.e1-574.e7. PubMed ID: 20144472 [TBL] [Abstract][Full Text] [Related]
31. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment. Calderón MA; Vidal C; Rodríguez Del Río P; Just J; Pfaar O; Tabar AI; Sánchez-Machín I; Bubel P; Borja J; Eberle P; Reiber R; Bouvier M; Lepelliez A; Klimek L; Demoly P; Allergy; 2017 Mar; 72(3):462-472. PubMed ID: 27718250 [TBL] [Abstract][Full Text] [Related]
32. One century of allergen-specific immunotherapy for respiratory allergy. Incorvaia C; Frati F Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092 [TBL] [Abstract][Full Text] [Related]
33. Better documentation through standardized forms: what progress have we made since the 1800s? Cox L Allergy Asthma Proc; 2004; 25(6):407-22. PubMed ID: 15709452 [TBL] [Abstract][Full Text] [Related]
34. Safety of rush immunotherapy to multiple aeroallergens in an adult population. Harvey SM; Laurie S; Hilton K; Khan DA Ann Allergy Asthma Immunol; 2004 Apr; 92(4):414-9. PubMed ID: 15104192 [TBL] [Abstract][Full Text] [Related]
35. [Current status of allergen-specific immunotherapy on perennial allergic rhinitis]. Okano M Arerugi; 2008 Feb; 57(2):79-85. PubMed ID: 18349581 [No Abstract] [Full Text] [Related]